First mRNA influenza vaccine launched; suitable for people aged 50 and older
Moderna’s first mRNA-based influenza vaccine, “mFlusiva,” is now available in pharmacies, though not everyone is eligible to receive it. The FDA approved mFlusiva for individuals aged 50 and older back in August, and the CDC recommends that eligible individuals complete their vaccination by the end of October. According to NBC News, the FDA granted traditional […]